Barbara McCoy

851 total citations
27 papers, 636 citations indexed

About

Barbara McCoy is a scholar working on Immunology, Hematology and Genetics. According to data from OpenAlex, Barbara McCoy has authored 27 papers receiving a total of 636 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 16 papers in Hematology and 8 papers in Genetics. Recurrent topics in Barbara McCoy's work include Immunodeficiency and Autoimmune Disorders (19 papers), Platelet Disorders and Treatments (15 papers) and Blood disorders and treatments (8 papers). Barbara McCoy is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (19 papers), Platelet Disorders and Treatments (15 papers) and Blood disorders and treatments (8 papers). Barbara McCoy collaborates with scholars based in United States, United Kingdom and Germany. Barbara McCoy's co-authors include Caroline Lassnig, Pavel Kovarik, Thomas Decker, Klaus Pfeffer, Heike Schindler, Marina Karaghiosoff, Hanspeter Pircher, Mathias Müller, Г. Брем and Hans Neubauer and has published in prestigious journals such as Immunity, Journal of Allergy and Clinical Immunology and Critical Care Medicine.

In The Last Decade

Barbara McCoy

25 papers receiving 608 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara McCoy United States 9 441 218 190 109 92 27 636
Kenichi Aoki Japan 11 267 0.6× 254 1.2× 87 0.5× 55 0.5× 63 0.7× 27 564
Morgan L. McLemore United States 12 213 0.5× 213 1.0× 224 1.2× 136 1.2× 122 1.3× 38 579
Julie Parmentier United States 8 136 0.3× 165 0.8× 116 0.6× 63 0.6× 124 1.3× 18 598
Britta Maecker Germany 16 525 1.2× 398 1.8× 146 0.8× 53 0.5× 49 0.5× 22 875
Kouji Kato Japan 8 244 0.6× 219 1.0× 57 0.3× 33 0.3× 57 0.6× 10 459
James Proulx United States 4 551 1.2× 166 0.8× 153 0.8× 87 0.8× 31 0.3× 4 827
Julie A. Di Paolo United States 9 168 0.4× 134 0.6× 116 0.6× 24 0.2× 131 1.4× 17 521
Ugo Consoli Italy 17 239 0.5× 395 1.8× 257 1.4× 46 0.4× 181 2.0× 36 863
Marina Lanciotti Italy 17 204 0.5× 129 0.6× 160 0.8× 215 2.0× 68 0.7× 51 733
R Bataille France 9 219 0.5× 372 1.7× 371 2.0× 34 0.3× 52 0.6× 13 707

Countries citing papers authored by Barbara McCoy

Since Specialization
Citations

This map shows the geographic impact of Barbara McCoy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara McCoy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara McCoy more than expected).

Fields of papers citing papers by Barbara McCoy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara McCoy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara McCoy. The network helps show where Barbara McCoy may publish in the future.

Co-authorship network of co-authors of Barbara McCoy

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara McCoy. A scholar is included among the top collaborators of Barbara McCoy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara McCoy. Barbara McCoy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Patel, Niraj, Jolán E. Walter, Richard L. Wasserman, et al.. (2025). Efficacy, Safety, Tolerability, and Serum IgG Trough Levels of Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 10% in US Pediatric Patients with Primary Immunodeficiency Diseases. Journal of Clinical Immunology. 45(1). 81–81. 1 indexed citations
2.
3.
Čižnár, Peter, Marion Roderick, Miloš Jeseňák, et al.. (2024). fSCIG 10% in pediatric primary immunodeficiency diseases: a European post-authorization safety study. Allergy Asthma and Clinical Immunology. 20(1). 47–47. 1 indexed citations
4.
5.
Ellerbroek, Pauline M., Leif G. Hanitsch, Torsten Witte, et al.. (2024). Long-term safety of hyaluronidase-facilitated subcutaneous immunoglobulin 10%: a European post-authorization study. Immunotherapy. 16(10). 679–691. 2 indexed citations
6.
Borte, Michael, M Hrubiško, Karina Jahnz‐Różyk, et al.. (2022). Long-Term Safety of Facilitated Subcutaneous Immunoglobulin Treatment in Pregnant Women with Primary Immunodeficiency Diseases: Results from a Registry Study. Immunotherapy. 14(8). 609–616. 3 indexed citations
7.
8.
Li, Zhaoyang, Barbara McCoy, Werner Engl, & Leman Yel. (2021). Steady-State Serum IgG Trough Levels Are Adequate for Pharmacokinetic Assessment in Patients with Immunodeficiencies Receiving Subcutaneous Immune Globulin. Journal of Clinical Immunology. 41(6). 1331–1338. 1 indexed citations
9.
10.
Gupta, Sudhir, Mark R. Stein, Iftikhar Hussaın, et al.. (2019). Tolerability of Ig20Gly during onboarding in patients with primary immunodeficiency diseases. Annals of Allergy Asthma & Immunology. 123(3). 271–279.e1. 3 indexed citations
11.
12.
Paris, Kenneth, Élie Haddad, Michael Borte, et al.. (2019). Tolerability of Subcutaneous Immunoglobulin 20%, Ig20Gly, in Pediatric Patients with Primary Immunodeficiencies. Immunotherapy. 11(5). 397–406. 8 indexed citations
13.
Suez, Daniel, Mark R. Stein, Sudhir Gupta, et al.. (2016). Efficacy, Safety, and Pharmacokinetics of a Novel Human Immune Globulin Subcutaneous, 20 % in Patients with Primary Immunodeficiency Diseases in North America. Journal of Clinical Immunology. 36(7). 700–712. 48 indexed citations
14.
Misbah, Siraj, Pere Soler‐Palacín, Barbara McCoy, et al.. (2015). Human Immunoglobulin (KIOVIG ® /GAMMAGARD LIQUID ® ) for Immunodeficiency and Autoimmune Diseases: An Observational Cohort Study. Immunotherapy. 7(7). 753–763. 5 indexed citations
15.
Wasserman, Richard L., Isaac Melamed, Mark R. Stein, et al.. (2012). Recombinant human hyaluronidase-facilitated subcutaneous infusion of human immunoglobulins for primary immunodeficiency. Journal of Allergy and Clinical Immunology. 130(4). 951–957.e11. 111 indexed citations
16.
Lewis, David L., et al.. (2005). Translating Evidence into Practice: The Case of Dementia Guidelines in Specialized Geriatric Services. Canadian Journal on Aging / La Revue canadienne du vieillissement. 24(3). 251–260. 6 indexed citations
17.
Karaghiosoff, Marina, Hans Neubauer, Caroline Lassnig, et al.. (2000). Partial Impairment of Cytokine Responses in Tyk2-Deficient Mice. Immunity. 13(4). 549–560. 338 indexed citations
18.
Jain, Sushil K., et al.. (1994). Vitamin E and the hypercoagulability of neonatal blood. Clinica Chimica Acta. 225(2). 97–103. 4 indexed citations
19.
Boutte, Gloria Swindler & Barbara McCoy. (1993). Racial Issues in Education: Real or Imagined?.. Young children. 49(1). 19–23. 10 indexed citations
20.
McCoy, Barbara, et al.. (1977). Elevated collagen synthesis in cultured keloid fibroblasts.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 28. 526–7. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenichi Aoki Breakdown of academic impact, for papers by Morgan L. McLemore Breakdown of academic impact, for papers by Julie Parmentier Breakdown of academic impact, for papers by Britta Maecker Breakdown of academic impact, for papers by Kouji Kato Breakdown of academic impact, for papers by James Proulx Breakdown of academic impact, for papers by Julie A. Di Paolo Breakdown of academic impact, for papers by Ugo Consoli Breakdown of academic impact, for papers by Marina Lanciotti Breakdown of academic impact, for papers by R Bataille
Rankless by CCL
2026